back to cluster viewer
cluster path 10100101011111
210 words, 8,730 tokens
freq alpha suffix
Words in frequency order
1 | febrile | 2,473
|
2 | lupus | 1,185
|
3 | sick | 1,117
|
4 | orthostatic | 801
|
5 | hemolytic | 421
|
6 | chemotherapy-induced | 411
|
7 | bulimia | 356
|
8 | intradialytic | 232
|
9 | vasovagal | 193
|
10 | unprovoked | 149
|
11 | aplastic | 135
|
12 | haemolytic | 135
|
13 | paralytic | 123
|
14 | heparin-induced | 120
|
15 | iron-deficiency | 85
|
16 | tuberous | 79
|
17 | first-dose | 60
|
18 | androgenetic | 57
|
19 | euvolemic | 34
|
20 | smoldering | 31
|
21 | sickle-cell | 28
|
22 | feverish | 26
|
23 | dilutional | 18
|
24 | hypophosphatemic | 18
|
25 | g3-4 | 17
|
26 | macrocytic | 17
|
27 | consumptive | 15
|
28 | dialysis-induced | 14
|
29 | microcytic | 14
|
30 | megaloblastic | 13
|
31 | normocytic | 13
|
32 | ribavirin-induced | 11
|
33 | malaria-associated | 10
|
34 | argyreia | 9
|
35 | hypoproliferative | 8
|
36 | nonblanching | 8
|
37 | normochromic | 8
|
38 | ganglionated | 7
|
39 | hypocalciuric | 7
|
40 | anti-gbm | 6
|
41 | heparin-associated | 5
|
42 | non-haemolytic | 5
|
43 | post-haemorrhagic | 5
|
44 | sideroblastic | 5
|
45 | sideropenic | 5
|
46 | tilt-induced | 5
|
47 | fe-deficiency | 4
|
48 | icu-associated | 4
|
49 | malaria-induced | 4
|
50 | nondocumented | 4
|
51 | pasireotide-associated | 4
|
52 | post-splenectomy | 4
|
53 | rebreathing-induced | 4
|
54 | 'cuff | 3
|
55 | arb-related | 3
|
56 | esa-hyporesponsive | 3
|
57 | fixed-value | 3
|
58 | hypoferremic | 3
|
59 | nonotologic | 3
|
60 | post-photorefractive | 3
|
61 | spinal-induced | 3
|
62 | uremia-associated | 3
|
63 | 'frequent | 2
|
64 | 12,386 | 2
|
65 | 27664 | 2
|
66 | 3,333 | 2
|
67 | 31,202 | 2
|
68 | 4966 | 2
|
69 | 5,190 | 2
|
70 | 5168 | 2
|
71 | agnogenic | 2
|
72 | amb-induced | 2
|
73 | antimicrobial-induced | 2
|
74 | aps-associated | 2
|
75 | auto-correction | 2
|
76 | azt-related | 2
|
77 | bleeding-spotting | 2
|
78 | calcium-deficiency | 2
|
79 | dse-induced | 2
|
80 | dysosma | 2
|
81 | early-dose | 2
|
82 | hal-associated | 2
|
83 | hug-csf-induced | 2
|
84 | infection/febrile | 2
|
85 | mahatriphaladya | 2
|
86 | micromeria | 2
|
87 | nonpsoriatic | 2
|
88 | one-or | 2
|
89 | peri-dosing | 2
|
90 | plasmacell | 2
|
91 | rbv-induced | 2
|
92 | rosacea-associated | 2
|
93 | teicoplanin-induced | 2
|
94 | tmp-smx-induced | 2
|
95 | vascular/glomerular | 2
|
96 | 'falls | 1
|
97 | 'lupus | 1
|
98 | -65/german-speaking | 1
|
99 | -hyporesponsive | 1
|
100 | -intake-induced | 1
|
101 | 11,709 | 1
|
102 | 128,260 | 1
|
103 | 13,205 | 1
|
104 | 15,133 | 1
|
105 | 15,936 | 1
|
106 | 19,843 | 1
|
107 | 2-agonist-induced | 1
|
108 | 22,970 | 1
|
109 | 24,069 | 1
|
110 | 25,035 | 1
|
111 | 3,7,3'-trimethyl | 1
|
112 | 38,381 | 1
|
113 | 39,124 | 1
|
114 | 4,101 | 1
|
115 | 4714 | 1
|
116 | 56,586 | 1
|
117 | 7880 | 1
|
118 | 8298 | 1
|
119 | 8848 | 1
|
120 | 9,162 | 1
|
121 | 9250 | 1
|
122 | abz-induced | 1
|
123 | alfacalcidol-induced | 1
|
124 | amegakaryocytic | 1
|
125 | andro-genetic | 1
|
126 | anoxrexia | 1
|
127 | atropine-requiring | 1
|
128 | beta-blockade-induced | 1
|
129 | caf-induced | 1
|
130 | cervciogenic | 1
|
131 | cheilostomate | 1
|
132 | circulation-induced | 1
|
133 | ckd/no | 1
|
134 | der-related | 1
|
135 | diamond-blackfan | 1
|
136 | dsm-iii-diagnosed | 1
|
137 | edema/fetal | 1
|
138 | eoc-patients | 1
|
139 | esa-resistant | 1
|
140 | eze/simvain | 1
|
141 | gln151 | 1
|
142 | grade-0/1 | 1
|
143 | haemorrhage-induced | 1
|
144 | hem-induced | 1
|
145 | hexapole | 1
|
146 | heymann | 1
|
147 | hyper-reninemic | 1
|
148 | hyperglcemia | 1
|
149 | hypervolemic/euvolemic | 1
|
150 | indapamide-related | 1
|
151 | intetumumab-related | 1
|
152 | intraislet | 1
|
153 | iso-associated | 1
|
154 | kci-induced | 1
|
155 | kwashiorkor/marasmic | 1
|
156 | labetalol-induced | 1
|
157 | leuko-and | 1
|
158 | low-income/temporary | 1
|
159 | luseogliflozin-induced | 1
|
160 | maximal-electroshock | 1
|
161 | melphalan-related | 1
|
162 | methyl-deuterated | 1
|
163 | more-conventional | 1
|
164 | myelofibrosis-associated | 1
|
165 | neonatal-infantile | 1
|
166 | non-deficiency | 1
|
167 | non-hypovolemic | 1
|
168 | nonacidemic | 1
|
169 | nonhypovolemic | 1
|
170 | nonregenerative | 1
|
171 | off-phase | 1
|
172 | p-deficiency | 1
|
173 | peg-ifnα-associated | 1
|
174 | pi/developing | 1
|
175 | post-loaded | 1
|
176 | post-postprandial | 1
|
177 | post-sab | 1
|
178 | postmalarial | 1
|
179 | pthrp-associated | 1
|
180 | putty-and | 1
|
181 | quinine-induced | 1
|
182 | reduction=0.00 | 1
|
183 | reduction=0.30 | 1
|
184 | refeeding-induced | 1
|
185 | ruxolitinib-associated | 1
|
186 | sandstorm-induced | 1
|
187 | sas-related | 1
|
188 | sc-inf-alpha-2a/iv | 1
|
189 | schonlein-henoch | 1
|
190 | skin-can | 1
|
191 | specified-anorexia | 1
|
192 | spontaneous/unprovoked | 1
|
193 | stabilizer-induced | 1
|
194 | surperimposing | 1
|
195 | thiazide-associated | 1
|
196 | thiopental-induced | 1
|
197 | thiophene-annulation | 1
|
198 | thl-induced | 1
|
199 | thl-related | 1
|
200 | tolvaptan-resistant | 1
|
201 | transient/self-limiting | 1
|
202 | treatment-needed | 1
|
203 | ts-1-induced | 1
|
204 | turning-induced | 1
|
205 | uropathy-related | 1
|
206 | video-head | 1
|
207 | vitamin-resistant | 1
|
208 | vrcz-associated | 1
|
209 | zidovudine-related | 1
|
210 | β-blocker-mediated | 1
|
Words in alphabetical order
1 | 'cuff | 3
|
2 | 'falls | 1
|
3 | 'frequent | 2
|
4 | 'lupus | 1
|
5 | -65/german-speaking | 1
|
6 | -hyporesponsive | 1
|
7 | -intake-induced | 1
|
8 | 11,709 | 1
|
9 | 12,386 | 2
|
10 | 128,260 | 1
|
11 | 13,205 | 1
|
12 | 15,133 | 1
|
13 | 15,936 | 1
|
14 | 19,843 | 1
|
15 | 2-agonist-induced | 1
|
16 | 22,970 | 1
|
17 | 24,069 | 1
|
18 | 25,035 | 1
|
19 | 27664 | 2
|
20 | 3,333 | 2
|
21 | 3,7,3'-trimethyl | 1
|
22 | 31,202 | 2
|
23 | 38,381 | 1
|
24 | 39,124 | 1
|
25 | 4,101 | 1
|
26 | 4714 | 1
|
27 | 4966 | 2
|
28 | 5,190 | 2
|
29 | 5168 | 2
|
30 | 56,586 | 1
|
31 | 7880 | 1
|
32 | 8298 | 1
|
33 | 8848 | 1
|
34 | 9,162 | 1
|
35 | 9250 | 1
|
36 | abz-induced | 1
|
37 | agnogenic | 2
|
38 | alfacalcidol-induced | 1
|
39 | amb-induced | 2
|
40 | amegakaryocytic | 1
|
41 | andro-genetic | 1
|
42 | androgenetic | 57
|
43 | anoxrexia | 1
|
44 | anti-gbm | 6
|
45 | antimicrobial-induced | 2
|
46 | aplastic | 135
|
47 | aps-associated | 2
|
48 | arb-related | 3
|
49 | argyreia | 9
|
50 | atropine-requiring | 1
|
51 | auto-correction | 2
|
52 | azt-related | 2
|
53 | beta-blockade-induced | 1
|
54 | bleeding-spotting | 2
|
55 | bulimia | 356
|
56 | caf-induced | 1
|
57 | calcium-deficiency | 2
|
58 | cervciogenic | 1
|
59 | cheilostomate | 1
|
60 | chemotherapy-induced | 411
|
61 | circulation-induced | 1
|
62 | ckd/no | 1
|
63 | consumptive | 15
|
64 | der-related | 1
|
65 | dialysis-induced | 14
|
66 | diamond-blackfan | 1
|
67 | dilutional | 18
|
68 | dse-induced | 2
|
69 | dsm-iii-diagnosed | 1
|
70 | dysosma | 2
|
71 | early-dose | 2
|
72 | edema/fetal | 1
|
73 | eoc-patients | 1
|
74 | esa-hyporesponsive | 3
|
75 | esa-resistant | 1
|
76 | euvolemic | 34
|
77 | eze/simvain | 1
|
78 | fe-deficiency | 4
|
79 | febrile | 2,473
|
80 | feverish | 26
|
81 | first-dose | 60
|
82 | fixed-value | 3
|
83 | g3-4 | 17
|
84 | ganglionated | 7
|
85 | gln151 | 1
|
86 | grade-0/1 | 1
|
87 | haemolytic | 135
|
88 | haemorrhage-induced | 1
|
89 | hal-associated | 2
|
90 | hem-induced | 1
|
91 | hemolytic | 421
|
92 | heparin-associated | 5
|
93 | heparin-induced | 120
|
94 | hexapole | 1
|
95 | heymann | 1
|
96 | hug-csf-induced | 2
|
97 | hyper-reninemic | 1
|
98 | hyperglcemia | 1
|
99 | hypervolemic/euvolemic | 1
|
100 | hypocalciuric | 7
|
101 | hypoferremic | 3
|
102 | hypophosphatemic | 18
|
103 | hypoproliferative | 8
|
104 | icu-associated | 4
|
105 | indapamide-related | 1
|
106 | infection/febrile | 2
|
107 | intetumumab-related | 1
|
108 | intradialytic | 232
|
109 | intraislet | 1
|
110 | iron-deficiency | 85
|
111 | iso-associated | 1
|
112 | kci-induced | 1
|
113 | kwashiorkor/marasmic | 1
|
114 | labetalol-induced | 1
|
115 | leuko-and | 1
|
116 | low-income/temporary | 1
|
117 | lupus | 1,185
|
118 | luseogliflozin-induced | 1
|
119 | macrocytic | 17
|
120 | mahatriphaladya | 2
|
121 | malaria-associated | 10
|
122 | malaria-induced | 4
|
123 | maximal-electroshock | 1
|
124 | megaloblastic | 13
|
125 | melphalan-related | 1
|
126 | methyl-deuterated | 1
|
127 | microcytic | 14
|
128 | micromeria | 2
|
129 | more-conventional | 1
|
130 | myelofibrosis-associated | 1
|
131 | neonatal-infantile | 1
|
132 | non-deficiency | 1
|
133 | non-haemolytic | 5
|
134 | non-hypovolemic | 1
|
135 | nonacidemic | 1
|
136 | nonblanching | 8
|
137 | nondocumented | 4
|
138 | nonhypovolemic | 1
|
139 | nonotologic | 3
|
140 | nonpsoriatic | 2
|
141 | nonregenerative | 1
|
142 | normochromic | 8
|
143 | normocytic | 13
|
144 | off-phase | 1
|
145 | one-or | 2
|
146 | orthostatic | 801
|
147 | p-deficiency | 1
|
148 | paralytic | 123
|
149 | pasireotide-associated | 4
|
150 | peg-ifnα-associated | 1
|
151 | peri-dosing | 2
|
152 | pi/developing | 1
|
153 | plasmacell | 2
|
154 | post-haemorrhagic | 5
|
155 | post-loaded | 1
|
156 | post-photorefractive | 3
|
157 | post-postprandial | 1
|
158 | post-sab | 1
|
159 | post-splenectomy | 4
|
160 | postmalarial | 1
|
161 | pthrp-associated | 1
|
162 | putty-and | 1
|
163 | quinine-induced | 1
|
164 | rbv-induced | 2
|
165 | rebreathing-induced | 4
|
166 | reduction=0.00 | 1
|
167 | reduction=0.30 | 1
|
168 | refeeding-induced | 1
|
169 | ribavirin-induced | 11
|
170 | rosacea-associated | 2
|
171 | ruxolitinib-associated | 1
|
172 | sandstorm-induced | 1
|
173 | sas-related | 1
|
174 | sc-inf-alpha-2a/iv | 1
|
175 | schonlein-henoch | 1
|
176 | sick | 1,117
|
177 | sickle-cell | 28
|
178 | sideroblastic | 5
|
179 | sideropenic | 5
|
180 | skin-can | 1
|
181 | smoldering | 31
|
182 | specified-anorexia | 1
|
183 | spinal-induced | 3
|
184 | spontaneous/unprovoked | 1
|
185 | stabilizer-induced | 1
|
186 | surperimposing | 1
|
187 | teicoplanin-induced | 2
|
188 | thiazide-associated | 1
|
189 | thiopental-induced | 1
|
190 | thiophene-annulation | 1
|
191 | thl-induced | 1
|
192 | thl-related | 1
|
193 | tilt-induced | 5
|
194 | tmp-smx-induced | 2
|
195 | tolvaptan-resistant | 1
|
196 | transient/self-limiting | 1
|
197 | treatment-needed | 1
|
198 | ts-1-induced | 1
|
199 | tuberous | 79
|
200 | turning-induced | 1
|
201 | unprovoked | 149
|
202 | uremia-associated | 3
|
203 | uropathy-related | 1
|
204 | vascular/glomerular | 2
|
205 | vasovagal | 193
|
206 | video-head | 1
|
207 | vitamin-resistant | 1
|
208 | vrcz-associated | 1
|
209 | zidovudine-related | 1
|
210 | β-blocker-mediated | 1
|
Words in suffix order
1 | reduction=0.00 | 1
|
2 | reduction=0.30 | 1
|
3 | 9250 | 1
|
4 | 128,260 | 1
|
5 | 22,970 | 1
|
6 | 7880 | 1
|
7 | 5,190 | 2
|
8 | grade-0/1 | 1
|
9 | 4,101 | 1
|
10 | gln151 | 1
|
11 | 38,381 | 1
|
12 | 31,202 | 2
|
13 | 9,162 | 1
|
14 | 15,133 | 1
|
15 | 3,333 | 2
|
16 | 19,843 | 1
|
17 | g3-4 | 17
|
18 | 4714 | 1
|
19 | 39,124 | 1
|
20 | 27664 | 2
|
21 | 13,205 | 1
|
22 | 25,035 | 1
|
23 | 15,936 | 1
|
24 | 4966 | 2
|
25 | 12,386 | 2
|
26 | 56,586 | 1
|
27 | 8848 | 1
|
28 | 5168 | 2
|
29 | 8298 | 1
|
30 | 11,709 | 1
|
31 | 24,069 | 1
|
32 | argyreia | 9
|
33 | hyperglcemia | 1
|
34 | bulimia | 356
|
35 | micromeria | 2
|
36 | specified-anorexia | 1
|
37 | anoxrexia | 1
|
38 | dysosma | 2
|
39 | mahatriphaladya | 2
|
40 | post-sab | 1
|
41 | post-haemorrhagic | 5
|
42 | nonotologic | 3
|
43 | nonacidemic | 1
|
44 | non-hypovolemic | 1
|
45 | nonhypovolemic | 1
|
46 | euvolemic | 34
|
47 | hypervolemic/euvolemic | 1
|
48 | hyper-reninemic | 1
|
49 | hypoferremic | 3
|
50 | hypophosphatemic | 18
|
51 | normochromic | 8
|
52 | kwashiorkor/marasmic | 1
|
53 | cervciogenic | 1
|
54 | agnogenic | 2
|
55 | sideropenic | 5
|
56 | hypocalciuric | 7
|
57 | nonpsoriatic | 2
|
58 | orthostatic | 801
|
59 | andro-genetic | 1
|
60 | androgenetic | 57
|
61 | megaloblastic | 13
|
62 | sideroblastic | 5
|
63 | aplastic | 135
|
64 | normocytic | 13
|
65 | macrocytic | 17
|
66 | microcytic | 14
|
67 | amegakaryocytic | 1
|
68 | intradialytic | 232
|
69 | paralytic | 123
|
70 | haemolytic | 135
|
71 | non-haemolytic | 5
|
72 | hemolytic | 421
|
73 | video-head | 1
|
74 | ts-1-induced | 1
|
75 | malaria-induced | 4
|
76 | amb-induced | 2
|
77 | beta-blockade-induced | 1
|
78 | haemorrhage-induced | 1
|
79 | -intake-induced | 1
|
80 | quinine-induced | 1
|
81 | dse-induced | 2
|
82 | caf-induced | 1
|
83 | hug-csf-induced | 2
|
84 | refeeding-induced | 1
|
85 | rebreathing-induced | 4
|
86 | turning-induced | 1
|
87 | kci-induced | 1
|
88 | antimicrobial-induced | 2
|
89 | spinal-induced | 3
|
90 | thiopental-induced | 1
|
91 | thl-induced | 1
|
92 | alfacalcidol-induced | 1
|
93 | labetalol-induced | 1
|
94 | hem-induced | 1
|
95 | sandstorm-induced | 1
|
96 | teicoplanin-induced | 2
|
97 | heparin-induced | 120
|
98 | ribavirin-induced | 11
|
99 | luseogliflozin-induced | 1
|
100 | circulation-induced | 1
|
101 | stabilizer-induced | 1
|
102 | dialysis-induced | 14
|
103 | tilt-induced | 5
|
104 | 2-agonist-induced | 1
|
105 | rbv-induced | 2
|
106 | tmp-smx-induced | 2
|
107 | chemotherapy-induced | 411
|
108 | abz-induced | 1
|
109 | post-loaded | 1
|
110 | treatment-needed | 1
|
111 | unprovoked | 149
|
112 | spontaneous/unprovoked | 1
|
113 | dsm-iii-diagnosed | 1
|
114 | rosacea-associated | 2
|
115 | uremia-associated | 3
|
116 | malaria-associated | 10
|
117 | ruxolitinib-associated | 1
|
118 | pasireotide-associated | 4
|
119 | thiazide-associated | 1
|
120 | hal-associated | 2
|
121 | heparin-associated | 5
|
122 | iso-associated | 1
|
123 | pthrp-associated | 1
|
124 | myelofibrosis-associated | 1
|
125 | aps-associated | 2
|
126 | icu-associated | 4
|
127 | vrcz-associated | 1
|
128 | peg-ifnα-associated | 1
|
129 | β-blocker-mediated | 1
|
130 | intetumumab-related | 1
|
131 | arb-related | 3
|
132 | indapamide-related | 1
|
133 | zidovudine-related | 1
|
134 | thl-related | 1
|
135 | melphalan-related | 1
|
136 | der-related | 1
|
137 | sas-related | 1
|
138 | azt-related | 2
|
139 | uropathy-related | 1
|
140 | ganglionated | 7
|
141 | methyl-deuterated | 1
|
142 | nondocumented | 4
|
143 | leuko-and | 1
|
144 | putty-and | 1
|
145 | febrile | 2,473
|
146 | infection/febrile | 2
|
147 | neonatal-infantile | 1
|
148 | hexapole | 1
|
149 | off-phase | 1
|
150 | first-dose | 60
|
151 | early-dose | 2
|
152 | cheilostomate | 1
|
153 | fixed-value | 3
|
154 | -hyporesponsive | 1
|
155 | esa-hyporesponsive | 3
|
156 | hypoproliferative | 8
|
157 | nonregenerative | 1
|
158 | post-photorefractive | 3
|
159 | consumptive | 15
|
160 | 'cuff | 3
|
161 | nonblanching | 8
|
162 | -65/german-speaking | 1
|
163 | pi/developing | 1
|
164 | smoldering | 31
|
165 | atropine-requiring | 1
|
166 | peri-dosing | 2
|
167 | surperimposing | 1
|
168 | transient/self-limiting | 1
|
169 | bleeding-spotting | 2
|
170 | schonlein-henoch | 1
|
171 | feverish | 26
|
172 | sick | 1,117
|
173 | maximal-electroshock | 1
|
174 | vasovagal | 193
|
175 | post-postprandial | 1
|
176 | postmalarial | 1
|
177 | more-conventional | 1
|
178 | dilutional | 18
|
179 | edema/fetal | 1
|
180 | sickle-cell | 28
|
181 | plasmacell | 2
|
182 | 3,7,3'-trimethyl | 1
|
183 | anti-gbm | 6
|
184 | skin-can | 1
|
185 | diamond-blackfan | 1
|
186 | eze/simvain | 1
|
187 | heymann | 1
|
188 | thiophene-annulation | 1
|
189 | auto-correction | 2
|
190 | ckd/no | 1
|
191 | vascular/glomerular | 2
|
192 | one-or | 2
|
193 | 'falls | 1
|
194 | eoc-patients | 1
|
195 | tuberous | 79
|
196 | lupus | 1,185
|
197 | 'lupus | 1
|
198 | intraislet | 1
|
199 | esa-resistant | 1
|
200 | tolvaptan-resistant | 1
|
201 | vitamin-resistant | 1
|
202 | 'frequent | 2
|
203 | sc-inf-alpha-2a/iv | 1
|
204 | fe-deficiency | 4
|
205 | calcium-deficiency | 2
|
206 | non-deficiency | 1
|
207 | iron-deficiency | 85
|
208 | p-deficiency | 1
|
209 | post-splenectomy | 4
|
210 | low-income/temporary | 1
|